Is an ingestion of 1200 mg propranolol (non-selective β‑blocker) potentially fatal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is 1200 mg Propranolol Fatal?

Yes, a 1200 mg propranolol ingestion is potentially fatal and constitutes a severe overdose requiring immediate intensive care management. While survival is possible with aggressive treatment, this dose carries significant risk of life-threatening cardiovascular collapse, seizures, and death.

Dose-Toxicity Relationship

  • The threshold for severe toxicity in isolated propranolol overdose is approximately 2000 mg, where 53% of patients develop life-threatening complications including seizures, coma, cardiac arrest, or requirement for inotropic support. 1

  • At 1200 mg, you are approaching this critical threshold—this dose falls within the range (800–1200 mg) documented in case series of propranolol poisoning requiring extracorporeal treatment and intensive interventions. 2

  • Propranolol demonstrates a threshold dose-response pattern rather than linear toxicity: beyond approximately 2000 mg, symptoms dramatically worsen. However, severe toxicity including hypotension and bradycardia can occur at lower doses. 3

  • The lowest reported dose for hypotension in isolated propranolol overdose is 400 mg and for bradycardia is 800 mg, placing 1200 mg well within the range for serious cardiovascular effects. 1

Fatal Outcomes

  • Propranolol is the only beta-blocker consistently associated with death in overdose. 4

  • Documented fatalities have occurred at doses of 4000 mg and 16000 mg, but the 35 deaths reported in a recent UK series (2022–2023) included cases with lower doses, particularly when combined with other agents. 5

  • Cardiac arrest occurred in 3% of propranolol overdoses, with reported doses ranging from 2400–16000 mg. 1

  • The mortality rate in propranolol poisoning requiring extracorporeal treatment was 11%, underscoring the severity even with maximal intervention. 2

Life-Threatening Manifestations at This Dose

Cardiovascular Toxicity

  • Profound hypotension and bradycardia result from β1-blockade at the sinoatrial and atrioventricular nodes combined with reduced myocardial contractility, often refractory to standard vasopressors. 6

  • Cardiogenic shock develops from myocardial depression and severely reduced cardiac output. 6

  • QRS prolongation and sodium channel blockade occur due to propranolol's membrane-stabilizing properties; QRS >100 ms is significantly associated with seizure risk. 4

Neurological Toxicity

  • Propranolol is highly lipophilic and readily crosses the blood-brain barrier, causing delirium, coma, and seizures. 2

  • Seizures occurred in 8% of all propranolol overdoses, and in patients ingesting >2000 mg, two-thirds experienced seizures. 1, 4

  • Seizures are unique to propranolol among beta-blockers and represent a distinguishing feature of severe toxicity. 3, 4

Metabolic Derangements

  • Hypoglycemia is a recognized complication requiring continuous glucose monitoring. 2, 6

Critical Management Priorities

Immediate Resuscitation (Class I Recommendations)

  • Initiate vasopressor support immediately with norepinephrine or epinephrine for hypotension; high doses are typically required due to receptor blockade. 6

  • Avoid epinephrine in stable patients—it may provoke uncontrolled hypertension due to unopposed alpha-receptor stimulation. 7

  • Start high-dose insulin euglycemia therapy (HIET) for refractory hypotension: 1 U/kg IV bolus followed by 1–10 U/kg/h infusion with dextrose to maintain euglycemia. This improves myocardial inotropy independent of beta-receptors. 6

Second-Line Interventions (Class IIa)

  • Administer glucagon 5–10 mg IV bolus (or 50–150 mcg/kg), then 1–5 mg/h continuous infusion for positive chronotropic and inotropic effects; anticipate vomiting as a common side effect. 6, 7

  • Consider veno-arterial ECMO early for refractory cardiogenic shock unresponsive to maximal pharmacologic support; early consultation with ECMO services is critical. 6

Adjunctive Measures

  • Atropine (0.5–1 mg IV) may be attempted for bradycardia but is frequently ineffective in severe beta-blocker toxicity. 6, 7

  • Temporary cardiac pacing (transcutaneous initially, then transvenous) may be considered, though myocardial capture can be difficult due to depressed contractility. 6

Therapies to Avoid

  • Do NOT use intravenous lipid emulsion (ILE)—the 2023 AHA guidelines explicitly recommend against ILE for life-threatening beta-blocker poisoning (Class III recommendation). 6

  • Avoid ipecac-induced emesis—it has been temporally associated with cardiorespiratory arrest in propranolol overdose. 4

Decontamination

  • Gastric lavage and activated charcoal should be considered only if presentation is within 1–2 hours of ingestion and the airway is protected; propranolol's high volume of distribution (5.5 L/kg) limits the utility of extracorporeal removal. 6, 7

  • Hemodialysis is ineffective due to propranolol's large volume of distribution and high lipophilicity. 6

Monitoring Requirements

  • Continuous ECG monitoring for bradyarrhythmias, QRS widening, and conduction disturbances. 6

  • Arterial line placement for beat-to-beat blood pressure monitoring; consider pulmonary artery catheterization if cardiac index assessment is needed. 6

  • Hourly blood glucose checks during HIET with immediate treatment of hypoglycemia. 6

  • Serial serum potassium to detect dyskalemias. 2

  • Minimum observation period of 12 hours even if asymptomatic (due to potential delayed absorption), with 24–48 hours ICU monitoring for any symptomatic patient. 6

Prognostic Factors

  • Time to treatment is critical—delays between ingestion and intervention are associated with worse outcomes including irreversible cardiogenic shock and death. 8

  • Co-ingestion dramatically worsens prognosis, particularly with calcium-channel blockers, other cardioactive drugs, or sedatives; one death occurred with bisoprolol-verapamil co-ingestion. 2, 3

  • Favorable outcomes require early aggressive treatment with vasopressors, HIET, and ECMO availability. 6

Common Pitfalls

  • Underestimating the severity—cardiovascular symptoms typically appear within 2 hours but can be delayed; peak toxicity often occurs 6–12 hours post-ingestion. 2, 6

  • Relying solely on atropine or standard vasopressors—these are frequently ineffective; HIET and glucagon are essential. 6

  • Delaying ECMO consultation—early involvement improves survival in refractory shock. 6

  • Failing to monitor for seizures—propranolol's lipophilicity makes CNS toxicity common, especially with QRS >100 ms. 4

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.